Vaccitech

‘Katja has provided us with invaluable advice in communicating our company’s story to potential investors and partners, helping us to pull together new content for our investor deck, corporate fact sheet and website – all in a tight timescale. She is responsive and professional and brings a wealth of insight to her communications counsel.’

Graham Griffiths
CBO of Vaccitech

Objectives

To raise the profile of the company and its technology platform and products with potential partners and investors to support a Series B financing round
Media relations around newsflow including the partnering of its ChAdOx platform through Oxford University’s vaccine and AstraZeneca

Strategy

To craft clear and consistent messaging and new corporate materials including a new investor deck to support a Series B round
Piggybacking on Oxford University’s newsflow re its COVID-19 vaccine to raise the profile of Vaccitech’s ChAdOx technology platform and maintain its share of voice during the AstraZeneca licensing deal

Results

Extensive coverage in UK National media and global trade press
Peaked investor interest in Vaccitech due to high profile media exposure